Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma

Head and Neck

Volumn 31, Issue 3, 2009, Pages 346-354

  Chua, Melvin Lee Kiang ^a   Seng, Chuan Ong ^b   Wee, Joseph Tien Seng ^a   Ng, David Chee Eng ^b   Gao, Fei ^a   Tan, Terence Wee Kiat ^a   Kam, Weng Fong ^a   Eu, Tiong Chua ^a   Khoo, James Boon Kheng ^a   Low, John Seng Hooi ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Conventional work up; CT; Distant metastasis staging; FDG PET; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; BIOCHEMISTRY; BLOOD CELL COUNT; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; ENDEMIC DISEASE; FEMALE; FIBER OPTICS; HEPATITIS B; HEPATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; THORAX RADIOGRAPHY;

ADULT; AGED; CARCINOMA; DIAGNOSTIC IMAGING; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 62249202084     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20974     Document Type: Article

References (44)

1. Khor TH, Tan BC, Chua EJ, Chia KB. Distant metastases in nasopharyngeal carcinoma. Clin Radiol 1978;29:27-30.
2. Huang SC. Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys 1980;6:401-407.
3. Ahmad A, Stefani S. Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol 1986;33:194-197.
4. Vikram B, Mishra UB, Strong EW, Manolatos S. Patterns of failure in carcinoma of the nasopharynx: failure at distant sites. Head Neck Surg 1986;8:276-279.
5. Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996;77:2423-2431.
6. Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal cancer. Head Neck 2000;22:393-397.
7. Chambers MS, Rosenthal DI, Weber RS. Radiation-induced xerostomia. Head Neck 2007;29:58-63.
8. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and (18)F-FDG in oncology: a clinical update. Nucl Med Biol 1996;23:717-735.
9. Avril N, Rosé CA, Schelling M, et al. Breast imaging with positron emission tomography and fluorine-18fluorodeoxyglucose: use and limitations. J Clin Oncol 2000;18:3495-3502.
10. Reisser C, Haberkorn U, Strauss LG. The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumours. J Otolaryngol 1993;22:231-238.
11. Knopp MW, Bischoff H, Lorenz WJ, Van Kaick G. PET imaging of lung tumours and mediastinal lymphoma. Nucl Med Biol 1994;21:749-757.
12. Steinert HC, Huch RA, Buck A, et al. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995;195:705-709.
13. Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994;190:111-116.
14. Chang JT, Chan SC, Yen TC, et al. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 2005;62:501-507.
15. Liu FY, Lin CY, Chang JT, et al. (18)F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med 2007;48:1614-1619.
16. Yen TC, Chang JT, Ng SH, et al. The value of (18)F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med 2005;46:405-410.
17. Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron emission tomography.NEngl J Med 2000;343:254-261.
18. Lardinois D, Weder W, Hany TF, et al. Staging of nonsmall cell cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507.
19. Ng SH, Chang JT, Ko SH, et al. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology 1997;39:741-746.
20. Chong VF, Mukherji SK, Ng SH, et al. Nasopharyngeal carcinoma: review of how imaging affects staging. J Comput Assist Tomogr 1999;23:984-993.
21. Fleming ID,Cooper JS,Henson DE, et al, editors. American Joint Committee on Cancer AJCC cancer staging manual, 6th ed. New York: Springer; 2002.
22. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22.
23. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005;23:6730-6738.
24. Leung TW, Tung SY, Sze WK, et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck 2005;27:555-565.
25. Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-270.
26. Fong KW, Chua EJ, Chua ET, et al. Patient profile and survival in 270 computer tomography-staged patients with nasopharyngeal carcinoma treated at the Singapore General Hospital. Ann Acad Med Singapore 1996;25:341-346.
27. Sham JS, Cheung YK, Chan FL, Choy DT. Nasopharyngeal carcinoma: patterns of skeletal metastases. Br J Radiol 1990;63:202-205.
28. Leung SF, Teo PM, Shiu WW, Tsao SY, Leung TW. Clinical features and management of distant metastases of nasopharyngeal carcinoma. J Otolaryngol 1991;20:27-29.
29. Huang CJ, Leung SW, Lian SL, Wang CJ, Fang FM, Ho YH. Patterns of distant metastases in nasopharyngeal carcinoma. Kaohsiung J Med Sci 1996;12:229-234.
30. Hsu MM, Tu SM. Nasopharyngeal carcinoma in Taiwan. Clinical manifestations and results of therapy. Cancer 1983;52:362-368.
31. Liu FY, Chang JT, Wang HM, et al. [18F]Fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol 2006;24:599-604.
32. Ho CL. Clinical PET imaging- an Asian perspective. Ann Acad Med Singapore 2004;33:155-165.
33. Low SY, Eng P, Keng GH, Ng DC. Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis. Respirology 2006;11:84-89.
34. Hickeson M, Yun M, Matthies A, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging 2002;29:1639-1647.
35. Kumar MB, Lu JJ, Loh KS, et al. Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004;58:688-693.
36. Geara FB, Sanguineti G, Tucker SL, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol 1997;43:53-61.
37. Sham JS, Choy DT, Choi PH. Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure. Br J Radiol 1990;63:108-113.
38. Kwong DL, Sham JS, Choy DT. The effect of locoregional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int J Radiat Oncol Biol Phys 1994;30:1029-1036.
39. Chua DT, Sham JS, Kwong DL, Choy DT, Au GK, Wu PM. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis. Cancer 1996;78:202-210.
40. Serkova NJ, Spratlin JL, Eckhardt SG. NMR-based metabolomics: translational application and treatment of cancer. Curr Opin Mol Ther 2007;9:572-585.
41. Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 2007;84:63-69.
42. Zapotoczna A, Sasso G, Simpson J, Roach M III. Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer. Neoplasia 2007;9:455-463.
43. Ng SH, Liu HM, Ko SF, Hao SP, Chong VF. Posttreatment imaging of the nasopharynx. Eur J Radiol 2002;44:82-95.
44. Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol 2007;85:327-335.